Granulosa-Theca Cell Tumour

 

Epidemiology:

    • 5% of all ovarian tumours
    • post-menopausal women in 2/3rds of cases
      • but may be seen at all ages

 

Common sites:

    •  

 

Gross features:

    • unilateral usually
    • variable size
    • solid or cystic
    • yellow coloration in cut surface if hormonally active (lipid)
    • hemorrhage often
    • no necrosis usually

 

Histologic features:

    • small, cuboidal to polygonal cells
      • cytoplasm may be scanty or plenty and densely eosinophilic (luteinized)
      • oval or angulated nuclei
        • haphazardly oriented
        • longitudinal grooves often (coffee bean)
        • not significantly pleomorphic
        • mitotic rate  0-2 / 10HPF usually
    • sheets, anastomosing cords, or strands
    • Call-Exner bodies (only present in some cases) (important clue if present)
      • Follicles / Rosette-like / glandlike structures filled with an eosinophilic material
    • Stromal component:
      • Fibroblasts, theca cells, and/or lutein cells
      • Clusters or sheets
      • Cuboidal to polygonal cells
      • Rarely appearance of high-grade sarcoma
    • Conspicuous foci of old or recent hemorrhage often
    • Nuclear grading has been shown to correlate with prognosis
    • Luteinization may be present in some tumours
      • More plump cells with ample cytoplasm
    • Sertoli-stromal cell component may be present (<10% of tumour)
    • Juvenile Granulosa Cell Tumour (<30y):
      • Irregular or round to oval follicles
        • Vary in both size and shape
      • Surrounded by sheets or nodular aggregates of granulosa cells

 

Immunophenotype:

Marker:

Sensitivity:

Specificity:

 Inhibin

 High

any sex-cord stromal tumour 

Calretinin

 

 

Melan-A

 

Any sex-cord stromal tumour

EMA (neg)

 

 

CK7 (neg)

 

 

 

Molecular features:

    •  

 

Other features:

    • may elaborate large amounts of estrogen
      • rarely androgenic
    • small but distinct hazard of malignancy
      • tumours composed predominantly with theca cells are rarely malignant
      • indolent course
      • recurrences may occur 10-20y after removal of original tumour